盈利能力显著修复,期待AD/DC产品持续放量
Factoring in ads & games headwinds
–Soft consumption weighs on ad recovery
仑卡奈单抗AD治疗新适应症,在美递交上市申请
AD诊断行业研究报告(一):阿尔兹海默症新药即将在国内获批上市,如何判断AD诊断行业空间?
医药生物行业跟踪周报:阿尔兹海默症迎来里程碑进展,重点关注 AD检测等需求爆发增长
常规上游业务拐点已现,ad血检、glp-1中间体业务带来新增长点
Sri Lanka: Technical Assistance Report-Repeal of Simplified Value Added Tax and the Transition to Risk-Based Value Added Tax Refund Processing
中国阿尔兹海默症AD诊断行业报告
数字阵雷达催生AD/DA大需求,公司系核心玩家将深度受益